Conversely, capecitabine is metabolized to its active form, 5-FU, by thymidine phosphorylase, which is enriched in tumors7,8, and pharmacokinetic data indicate that PPIs might affect thymidine phosphorylase in tumor cells15. Here, TYMP is linked to neoplasm.